🇺🇸 FDA
Pipeline program

Fast Dual CAR-T Injection

211

Phase 1 mab terminated

Quick answer

Fast Dual CAR-T Injection for B-cell Lymphoma is a Phase 1 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
B-cell Lymphoma
Phase
Phase 1
Modality
mab
Status
terminated

Clinical trials